Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNPS vs GSK✓SelectedUSD · GSKSNPS vs GSK performance historyLatest closeAs of-8.06%11/20
Stock and ETF performance explorer

SNPS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+546.2%
GSK return
+97.4%
Excess return
+448.8%
Maximum drawdown
-43.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.1%-0.1%-7.9%-8.0%
7D-13.0%-5.3%-7.6%-11.7%
30D-12.2%-3.7%-8.5%-11.4%
3M-0.4%-7.3%+6.8%+1.2%
6M-20.6%-4.2%-16.4%-20.4%
YTD-15.7%+0.9%-16.5%-17.8%
1Y+2.7%+7.3%-4.5%-2.0%
3Y-26.8%+52.7%-79.6%-40.6%
5Y+10.7%+40.1%-29.4%-8.6%
All+546.2%+97.4%+448.8%+354.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling